Filing Details
- Accession Number:
- 0001209191-21-013037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-22 21:33:49
- Reporting Period:
- 2021-02-09
- Accepted Time:
- 2021-02-22 21:33:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124105 | Catalyst Biosciences Inc. | CBIO | Pharmaceutical Preparations (2834) | 562020050 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1206872 | Nassim Usman | 611 Gateway Boulevard, Suite 710 South San Francisco CA 94080 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-09 | 582 | $4.81 | 12,174 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 8,456 | Indirect | By The Usman Family Trust |
Common Stock | 1,168 | Indirect | By Nassim Usman IRA |
Footnotes
- Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2021.